Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Childhood obesity stories

Nov 16, 2026

Novo Nordisk's Wegovy shows weight-loss benefit in children as young as six

Novo Nordisk released full Phase 3 trial results showing Wegovy lowered BMI and obesity rates in children aged 6 and older, though younger children who took the drug showed reduced growth rates.

Nov 16, 2026·3 sources
00
Oct 7, 2026

WHO recommends against obesity drugs for children under 10

The World Health Organization issued its first global guidelines on childhood obesity, strongly recommending against GLP-1 weight-loss medications for children under age 10, citing unclear long-term effects. The guidance prioritizes diet, exercise and counseling instead.

Oct 7, 2026·3 sources
00
Sep 7, 2026

Novo Nordisk's Wegovy helps 40% of young children lose enough weight to no longer be obese in trial

In a late-stage trial, 40.4% of children aged 6 to under 12 treated with semaglutide (Wegovy's active ingredient) were no longer obese after treatment, compared to the control group.

Sep 7, 2026·2 sources
00
Jul 25, 2026

Italy faces severe childhood obesity crisis despite Mediterranean diet heritage

Italy, once a model for healthy eating with its Mediterranean diet, now confronts a major child obesity problem, with over 40% of children aged 8-9 overweight in some regions of Campania. The crisis represents a stark reversal for a country that inspired global healthy eating standards.

Jul 25, 2026·7 sources
00

Top claims

  • ▪Almost 80 percent of children aged 6 to under 12 given Wegovy in Novo Nordisk's trial reduced their body mass index by at least 10 percent over 68 weeks
  • ▪In the 68-week trial, 40 percent of children aged 6 to under 12 taking Wegovy were no longer classified as having obesity, compared with none in the placebo group
  • ▪As of November 16, 2026, Novo Nordisk has not announced if or when it will file for regulatory approval to treat children under 12 with Wegovy

Subtopics

Clinical trials2GLP-1 medications2Nutrition2Weight management2Adolescent health1Dietary patterns1Drug Policy, Pricing & Approval1Drug safety1Eli Lilly1Exercise & Fitness Training1GLP-1 drug side effects1GLP-1 drugs1Lifestyle, Wellness and Nutrition1Mediterranean diet1Novo Nordisk1Novo Nordisk1Obesity treatment1Pharma1Weight loss drugs1Weight loss medications & GLP-1 drugs1Zepbound1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories